lobbying_activities: 956354

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
956354	1df2a935-5831-44db-838d-b1d892b4467f	Q2	THE PETRIZZO GROUP, INC.	305932	AGIOS PHARMACEUTICALS, INC.	2010	second_quarter	MED	Advance proposal for federal funding in the FY 2011 Defense Appropriations bill for cancer metabolism drug discovery that will bring therapeutic hope to service men and women who are suffering from Acut Myeloid Leukemia and brain cancer (gliomas).	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2010-07-16T10:54:01.890000-04:00